VA
ZURA icon

VR Adviser’s Zura Bio ZURA Stock Holding History

VR Adviser’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.3M Buy
6,434,990
+1,089,875
+20% +$6.58M 1.43% 20
2025
Q4 		$28M Buy
5,345,115
+713,899
+15% +$2.82M 1.38% 20
2025
Q3 		$20.1M Hold
4,631,216
– – 1.13% 23
2025
Q2 		$4.86M Sell
4,631,216
-391,950
-8% -$469K 0.36% 28
2025
Q1 		$6.48M Buy
5,023,166
+3,000,000
+148% +$4.73M 0.55% 26
2024
Q4 		$5.06M Hold
2,023,166
– – 0.35% 31
2024
Q3 		$8.21M Sell
2,023,166
-4,000,000
-66% -$14.9M 0.43% 32
2024
Q2 		$21.1M Buy
+6,023,166
New +$24.6M 1.34% 23

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VR Adviser's ZURA Position: Q1 2026 in Review

VR Adviser increased its Zura Bio (ZURA) stake by 20% in Q1 2026, buying an estimated $6.58M and bringing the position to 6,434,990 shares worth $38.3M. The position accounts for 1.43% of the portfolio, ranked #20.

VR Adviser first reported a position in ZURA in Q2 2024 and has held it in 8 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • VR Adviser held 6,434,990 shares of Zura Bio worth $38.3M as of Q1 2026.
  • VR Adviser bought 1,089,875 Zura Bio shares in Q1 2026, an estimated $6.58M.
  • Zura Bio made up 1.43% of VR Adviser's portfolio in Q1 2026, its #20 holding.
  • VR Adviser first reported a position in Zura Bio in Q2 2024 and has held it in 8 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on VR Adviser's 13F filing for Q1 2026, filed 15 May 2026.